Clinical trials

  • BAXDROSTAT for Primary aldosteronism | Primary hyperaldosteronism
  • Trastuzumab deruxtecan for Metastatic breast cancer
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for Pulmonary arterial hypertension
  • BARZOLVOLIMAB for Cold-induced urticaria | Symptomatic dermographism
  • LAZERTINIB for Non-small cell lung cancer (EGFR-mutated) | Locally advanced or metastatic non-small cell lung cancer
  • VIPOGLANSTAT (GS-248) for Endometriosis
  • ERYTHROMYCIN for Surgical site infection
  • Clinical trial in Major depressive disorder | Incomplete Response - Major Depressive Disorder (IR-MDD)
  • DAROVASERTIB for Uveal melanoma
  • LUTIKIZUMAB for Rheumatoid arthritis
  • AZD5335 for Ovarian cancer | Primary peritoneal cancer | Fallopian tube cancer
  • Venetoclax for Acute myeloid leukemia | Myelodysplastic syndrome (higher-risk)